reference/5153838

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5153838

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	1158
issn	1556-0864
issueIdentifier	10
pageRange	1153-1158
publicationName	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
startingPage	1153
bibliographicCitation	Heist RS, Fidias P, Huberman M, Ardman B, Sequist LV, Temel JS, Lynch TJ. A phase II study of oxaliplatin, pemetrexed, and bevacizumab in previously treated advanced non-small cell lung cancer. J Thorac Oncol. 2008 Oct;3(10):1153–8. doi: 10.1097/jto.0b013e318187273f. PMID: 18827612.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8439844591cdbc47b868eb5cac54dc2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b4e8edc0bbe2061c64c9b296e23c919 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a7da1ef9851de6a0a911baa28e168e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c81819c8c559f32b7d547278a300a9e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f159ae3db0036f179aeda411d7e02ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd53a2380f2f83f6e4c754b6ea1b483b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13dcf5078e6f7913b58433304b43b3e3
date	200810
identifier	https://pubmed.ncbi.nlm.nih.gov/18827612 https://doi.org/10.1097/jto.0b013e318187273f
isPartOf	https://portal.issn.org/resource/ISSN/1556-0864 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33311
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	A Phase II Study of Oxaliplatin, Pemetrexed, and Bevacizumab in Previously Treated Advanced Non-small Cell Lung Cancer
discusses	http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M000754277 http://id.nlm.nih.gov/mesh/M0095550 http://id.nlm.nih.gov/mesh/M0443627 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0015422 http://id.nlm.nih.gov/mesh/M0005997
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D003841Q000008 http://id.nlm.nih.gov/mesh/D002282Q000556 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D000077150 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D009944Q000008 http://id.nlm.nih.gov/mesh/D001932Q000188 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D018287Q000556 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D002282Q000188 http://id.nlm.nih.gov/mesh/D018287Q000188 http://id.nlm.nih.gov/mesh/D000068258 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D000230Q000556 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000911Q000008 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D001932Q000556 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D008175Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7099 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9887053 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7215 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129281950 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764

Total number of triples: 74.